Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells

Journal of Immunology

Volumn 178, Issue 11, 2007, Pages 6949-6957

  Mendoza Naranjo, Ariadna ^a   Saéz, Pablo J ^b   Johansson, C Christian ^c   Ramírez, Marcos ^a   Mandaković, Dinka ^a   Pereda, Cristian ^a   López, Mercedes N ^a,d   Kiessling, Rolf ^c   Sáez, Juan C ^b   Salazar Onfray, Flavio ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c Karolinska Krankenhaus   (Sweden)

^d HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; MELANOMA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PATIENT; CELL COMMUNICATION; CELL LYSATE; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; GAP JUNCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MELANOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

EID: 34249811507     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.11.6949     Document Type: Article

References (32)

1. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118.
2. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4: 328-332.
3. Thurner, B., I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender, C. Maczek, D. Schreiner, P. von den Driesch, et al. 1999. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190: 1669-1678.
4. Escobar, A., M. Lopez, A. Serrano, M. Ramirez, C. Perez, A. Aguirre, R. Gonzalez, J. Alfaro, M. Larrondo, M. Fodor, et al. 2005. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients. Clin. Exp. Immunol. 142: 555-568.
5. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188: 2163-2173.
6. Harshyne, L. A., S. C. Watkins, A. Gambotto, and S. M. Barratt-Boyes. 2001. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. 166: 3717-3723.
7. Kleindienst, P., and T. Brocker. 2003. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J. Immunol. 170: 2817-2823.
8. Matsue, H., J. Yao, K. Matsue, A. Nagasaka, H. Sugiyama, R. Aoki, M. Kitamura, and S. Shimada. 2006. Gap junction-mediated intercellular communication between dendritic cells (DCs) is required for effective activation of DCs. J. Immunol. 176: 181-190.
9. Eugenin, E. A., M. C. Branes, J. W. Berman, and J. C. Saez. 2003. TNF-α plus IFN-γ induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J. Immunol. 170: 1320-1328.
10. Goodenough, D. A. 1975. The structure of cell membranes involved in intercellular communication. Am. J. Clin. Pathol. 63: 636-645.
11. Goodenough, D. A., J. A. Goliger, and D. L. Paul. 1996. Connexins, connexons, and intercellular communication. Annu. Rev. Biochem. 65: 475-502.
12. Neijssen, J., C. Herberts, J. W. Drijfhout, E. Reits, L. Janssen, and J. Neefjes. 2005. Cross-presentation by intercellular peptide transfer through gap junctions. Nature 434: 83-88.
13. Jara, P. I., M. P. Boric, and J. C. Saez. 1995. Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothelial cells after ischemia-reperfusion. Proc. Natl. Acad. Sci. USA 92: 7011-7015.
14. Krenacs, T., M. van Dartel, E. Lindhout, and M. Rosendaal. 1997. Direct cell/cell communication in the lymphoid germinal center: connexin43 gap junctions functionally couple follicular dendritic cells to each other and to B lymphocytes. Eur. J. Immunol. 27: 1489-1497.
15. Oviedo-Orta, E., P. Gasque, and W. H. Evans. 2001. Immunoglobulin and cytokine expression in mixed lymphocyte cultures is reduced by disruption of gap junction intercellular communication. FASEB J. 15: 768-774.
16. Oviedo-Orta, E., T. Hoy, and W. H. Evans. 2000. Intercellular communication in the immune system: differential expression of connexin40 and 43, and perturbation of gap junction channel functions in peripheral blood and tonsil human lymphocyte subpopulations. Immunology 99: 578-590.
17. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346: 425-434.
18. Concha, M., A. Vidal, G. Garces, C. D. Figueroa, and I. Caorsi. 1993. Physical interaction between Langerhans cells and T-lymphocytes during antigen presentation in vitro. J. Invest. Dermatol. 100: 429-434.
19. Brand, C. U., T. Hunziker, T. Schaffner, A. Limat, H. A. Gerber, and L. R. Braathen. 1995. Activated immunocompetent cells in human skin lymph derived from irritant contact dermatitis: an immunomorphological study. Br. J. Dermatol. 132: 39-45.
20. Retamal, M. A., C. J. Cortes, L. Reuss, M. V. Bennett, and J. C. Saez. 2006. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc. Natl. Acad. Sci. USA 103: 4475-4480.
21. Branes, M. C., J. E. Contreras, and J. C. Saez. 2002. Activation of human polymorphonuclear cells induces formation of functional gap junctions and expression of connexins. Med. Sci. Monit. 8: 313-323.
22. Saez, J. C., A. D. Martinez, M. C. Branes, and H. E. Gonzalez. 1998. Regulation of gap junctions by protein phosphorylation. Braz. J. Med. Biol. Res. 31: 593-600.
23. Delamarre, L., H. Holcombe, A. Giodini, and I. Mellman. 2003. Presentation of exogenous antigens on MHC class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J. Exp. Med. 198: 111-122.
24. Rosendaal, M., and C. Jopling. 2003. Hematopoietic capacity of connexin43 wild-type and knock-out fetal liver cells not different on wild-type stroma. Blood 101: 2996-2998.
25. Chanson, M., J. P. Derouette, I. Roth, B. Foglia, I. Scerri, T. Dudez, and B. R. Kwak. 2005. Gap junctional communication in tissue inflammation and repair. Biochim. Biophys. Acta 1711: 197-207.
26. Guan, X., B. F. Cravatt, G. R. Ehring, J. E. Hall, D. L. Boger, R. A. Lerner, and N. B. Gilula. 1997. The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. J. Cell Biol. 139: 1785-1792.
27. Guan, X., S. Wilson, K. K. Schlender, and R. J. Ruch. 1996. Gap-junction disassembly and connexin 43 dephosphorylation induced by 18 β- glycyrrhetinic acid. Mol. Carcinog. 16: 157-164.
28. Fields, R. C., K. Shimizu, and J. J. Mule. 1998. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 9482-9487.
29. Zitvogel, L., J. I. Mayordomo, T. Tjandrawan, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183: 87-97.
30. Denzer, K., M. J. Kleijmeer, H. F. Heijnen, W. Stoorvogel, and H. J. Geuze. 2000. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113(Pt. 19): 3365-3374.
31. Guermonprez, P., L. Saveanu, M. Kleijmeer, J. Davoust, P. Van Endert, and S. Amigorena. 2003. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425: 397-402.
32. Dhodapkar, K. M., J. Krasovsky, B. Williamson, and M. V. Dhodapkar. 2002. Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J. Exp. Med. 195: 125-133.